drugset / Trial / NCT01859377

Evaluation and Comparison of Systemic Exposure to Ibuprofen After Single Oromucosal Versus Oral Administrations

NCT01859377

Phase 1 Completed 26 enrolled Pierre Fabre Laboratories
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to evaluate the systemic exposure to ibuprofen after single oromucosal administration of the test product V0498 and single oral administration of a reference product.

Timeline

Start
2013-05
Primary completion
2013-06
Completion
2013-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Ibuprofen Small molecule Oral
Subject V0498 Unknown Other

Indications

No indication recorded.